These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16741923)

  • 1. Rising prostate cancer rates in South Korea.
    Park SK; Sakoda LC; Kang D; Chokkalingam AP; Lee E; Shin HR; Ahn YO; Shin MH; Lee CW; Lee DH; Blair A; Devesa SS; Hsing AW
    Prostate; 2006 Sep; 66(12):1285-91. PubMed ID: 16741923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorectal cancer among Koreans living in South Korea versus California: incidence, mortality, and screening rates.
    Ryu SY; Crespi CM; Maxwell AE
    Ethn Health; 2014 Aug; 19(4):406-23. PubMed ID: 23713441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer surveillance series: interpreting trends in prostate cancer--part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates.
    Hankey BF; Feuer EJ; Clegg LX; Hayes RB; Legler JM; Prorok PC; Ries LA; Merrill RM; Kaplan RS
    J Natl Cancer Inst; 1999 Jun; 91(12):1017-24. PubMed ID: 10379964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in the Incidence of Fatal Prostate Cancer in the United States by Race.
    Kelly SP; Rosenberg PS; Anderson WF; Andreotti G; Younes N; Cleary SD; Cook MB
    Eur Urol; 2017 Feb; 71(2):195-201. PubMed ID: 27476048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethnic differences in the age-related distribution of serum prostate-specific antigen values: a study in a healthy Korean male population.
    Lee SE; Kwak C; Park MS; Lee CH; Kang W; Oh SJ
    Urology; 2000 Dec; 56(6):1007-10. PubMed ID: 11113748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer incidence patterns in Koreans in the US and in Kangwha, South Korea.
    Gomez SL; Le GM; Clarke CA; Glaser SL; France AM; West DW
    Cancer Causes Control; 2003 Mar; 14(2):167-74. PubMed ID: 12749722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer and prostate-specific antigen testing in New South Wales.
    Smith DP; Supramaniam R; Marshall VR; Armstrong BK
    Med J Aust; 2008 Sep; 189(6):315-8. PubMed ID: 18803534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer surveillance series: interpreting trends in prostate cancer--part III: Quantifying the link between population prostate-specific antigen testing and recent declines in prostate cancer mortality.
    Etzioni R; Legler JM; Feuer EJ; Merrill RM; Cronin KA; Hankey BF
    J Natl Cancer Inst; 1999 Jun; 91(12):1033-9. PubMed ID: 10379966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. International trends and patterns of prostate cancer incidence and mortality.
    Hsing AW; Tsao L; Devesa SS
    Int J Cancer; 2000 Jan; 85(1):60-7. PubMed ID: 10585584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate cancer: an emerging threat to the health of aging men in Asia.
    Zhang L; Yang BX; Zhang HT; Wang JG; Wang HL; Zhao XJ
    Asian J Androl; 2011 Jul; 13(4):574-8. PubMed ID: 21552284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survey of incidence of urological cancer in South Korea: a 15-year summary.
    Cheon J; Kim CS; Lee ES; Hong SJ; Cho YH; Shin EC; Lee WC; Yoon MS
    Int J Urol; 2002 Aug; 9(8):445-54. PubMed ID: 12225342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening Prostate-specific Antigen Concentration and Prostate Cancer Mortality: The Korean Heart Study.
    Mok Y; Kimm H; Shin SY; Jee SH; Platz EA
    Urology; 2015 May; 85(5):1111-1116. PubMed ID: 25917733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer in Saskatchewan Canada, before and during the PSA era.
    Skarsgard D; Tonita J
    Cancer Causes Control; 2000 Jan; 11(1):79-88. PubMed ID: 10680732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Problems with prostate specific antigen screening for prostate cancer in the primary healthcare setting in South Africa.
    Heyns CF; Mathee S; Isaacs A; Kharwa A; De Beer PM; Pretorius MA
    BJU Int; 2003 Jun; 91(9):785-8. PubMed ID: 12780832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer surveillance series: interpreting trends in prostate cancer--part II: Cause of death misclassification and the recent rise and fall in prostate cancer mortality.
    Feuer EJ; Merrill RM; Hankey BF
    J Natl Cancer Inst; 1999 Jun; 91(12):1025-32. PubMed ID: 10379965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urban-rural differences in prostate cancer mortality, radical prostatectomy and prostate-specific antigen testing in Australia.
    Coory MD; Baade PD
    Med J Aust; 2005 Feb; 182(3):112-5. PubMed ID: 15698354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate cancer and prostate-specific antigen (PSA) screening in Austria.
    Vutuc C; Schernhammer ES; Haidinger G; Waldhör T
    Wien Klin Wochenschr; 2005 Jul; 117(13-14):457-61. PubMed ID: 16091872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changing Incidence of Metastatic Prostate Cancer by Race and Age, 1988-2015.
    Dall'Era MA; deVere-White R; Rodriguez D; Cress R
    Eur Urol Focus; 2019 Nov; 5(6):1014-1021. PubMed ID: 29735368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. East meets West: ethnic differences in prostate cancer epidemiology between East Asians and Caucasians.
    Kimura T
    Chin J Cancer; 2012 Sep; 31(9):421-9. PubMed ID: 22085526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rising incidence of prostate cancer in Scotland: increased risk or increased detection?
    Brewster DH; Fraser LA; Harris V; Black RJ
    BJU Int; 2000 Mar; 85(4):463-72; discussion 472-3. PubMed ID: 10691826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.